<DOC>
	<DOCNO>NCT01572636</DOCNO>
	<brief_summary>This standard care treatment guideline patient diagnosis mucopolysaccharidosis type IH ( MPS I , Hurler syndrome ) consider candidate first hematopoietic stem cell transplantation ( HSCT ) accord University Minnesota myeloablative HSCT protocol .</brief_summary>
	<brief_title>Laronidase ( Aldurazyme TM ) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant Hurler Syndrome</brief_title>
	<detailed_description>Laronidase Enzyme Replacement Therapy perform use laronidase week 12 week prior hematopoietic stem cell transplantation 8 week post-transplant reduce pulmonary complication .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Mucopolysaccharidoses</mesh_term>
	<mesh_term>Mucopolysaccharidosis I</mesh_term>
	<criteria>Diagnosis mucopolysaccharidosis type IH ( MPS I , Hurler syndrome ) consider candidate first transplant accord University Minnesota myeloablative hematopoietic stem cell transplant ( HSCT ) protocol No prior therapy laronidase enzyme replacement therapy ( ERT )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Hurler Syndrome</keyword>
</DOC>